Pasithea therapeutics stock news
WebProvide the latest Pasithea Therapeutics(KTTA) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company … WebPasithea Therapeutics Corp. historical stock charts and prices, analyst ratings, financials, and today’s real-time KTTA stock price. Dow Jones, ... News Corp is a global, diversified …
Pasithea therapeutics stock news
Did you know?
WebPasithea Therapeutics Chairman, Prof. Lawrence Steinman to Receive Pioneer in Medicine Award. Prestigious award presented by Society for Brain Mapping & Therapeutics (SBMT) and the World Brain Mapping FoundationPALO ALTO, Calif. and MIAMI, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the … Web3 Apr 2024 · Complete Pasithea Therapeutics Corp. Wt stock information by Barron's. View real-time KTTAW stock price and news, along with industry-best analysis.
WebPasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2024 and is headquartered in Miami Beach, FL. KTTA Price Targets What analysts think KTTA stock … Web31 Mar 2024 · KTTA: Get the latest Pasithea Therapeutics stock price and detailed information including KTTA news, historical charts and realtime prices.
Web15 Sep 2024 · Pasithea Therapeutics, a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, filed its registration statement... WebThe KTTA stock price is closed at $ 0.433900 with a total market cap valuation of $ 13.58M (44M shares outstanding). The KTTA is trading on NASDAQ with the sign KTTA. KTTA …
Web11 Apr 2024 · We forecast Pasithea Therapeutics stock performance using neural networks based on historical data on Pasithea Therapeutics stocks. Also, when forecasting, …
Web20 Mar 2024 · Pasithea Therapeutics Corp. Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses. coffea bengalensisWeb23 Dec 2024 · The company’s market capitalization is $44.239 million. KTTA stock is up 33.4% as of Thursday morning. There’s more stock market news to dive into below! … calvin yang psychiatristWebView the latest Pasithea Therapeutics Corp. (KTTA) stock price, news, historical charts, analyst ratings and financial information from WSJ. KTTA Pasithea Therapeutics Corp. … coffea anwendungWebPasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. … coffea arabica planteWeb11 Apr 2024 · A high-level overview of Pasithea Therapeutics Corp. (KTTA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment … calvin yatesWebPasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. … coffea bercyWeb15 Oct 2024 · Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq Capital Market on September 15, 2024, under the symbol “KTTA.” Pasithea Clinics has clinic partnerships both in the United States and in the United Kingdom to provide IV ketamine treatment. coffea benghalensis